Similar articles

• Novel camptothecin derivatives.

  Legarza K, Yang LX. Legarza K, et al. In Vivo. 2005 Jan-Feb;19(1):283-92. In Vivo. 2005. PMID: 15796188 Review.
• Synthesis and cytotoxic activity of new 9-substituted camptothecins.

  Dallavalle S, Rocchetta DG, Musso L, Merlini L, Morini G, Penco S, Tinelli S, Beretta GL, Zunino F. Dallavalle S, et al. Bioorg Med Chem Lett. 2008 May 1;18(9):2781-7. doi: 10.1016/j.bmcl.2008.04.016. Epub 2008 Apr 10. Bioorg Med Chem Lett. 2008. PMID: 18434153
• Camptothecin and its analogues: a review on their chemotherapeutic potential.

  Sriram D, Yogeeswari P, Thirumurugan R, Bal TR. Sriram D, et al. Nat Prod Res. 2005 Jun;19(4):393-412. doi: 10.1080/14786410412331299005. Nat Prod Res. 2005. PMID: 15938148 Review.
• [Synthesis of camptothecin glycosides by phase transfer-catalysis and its inhibitory activity against topo I].

  Li QY, Zhang Y, Yao LP, Fu YJ, Zu YG, Chen XQ, Zheng CY. Li QY, et al. Yao Xue Xue Bao. 2005 Dec;40(12):1116-21. Yao Xue Xue Bao. 2005. PMID: 16496676 Chinese.
• [Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].

  Yang S, Zhang WN. Yang S, et al. Yao Xue Xue Bao. 2004 May;39(5):396-400. Yao Xue Xue Bao. 2004. PMID: 15338888 Review. Chinese. No abstract available.